Literature DB >> 18003817

Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis.

Gary Toedter1, Karen Hayden, Carrie Wagner, Carrie Brodmerkel.   

Abstract

The accurate detection and quantitation of cytokines in serum are important in the study of disease mechanisms, pathogenesis, and treatment. Serum cytokines can reflect processes that are occurring at the cellular or tissue level and thus provide a means of indirectly monitoring these processes. Multiplex detection of cytokines allows the simultaneous measurement of multiple cytokines in a sample, increasing the efficiency of measuring the cytokines while reducing the serum sample volumes required for the testing. Two commercially available multiplex platforms were evaluated (Pierce SearchLight and Meso Scale Discovery), using multiplexes capable of simultaneously detecting eight cytokines. The cytokines analyzed in this study were gamma interferon, vascular endothelial growth factor, tumor necrosis factor alpha, interleukin-6 (IL-6), macrophage inflammatory protein 1beta, monocyte chemoattractant protein 1, IL-12p40, and IL-4. The range of quantitation of the platforms, the recovery of spiked cytokines, and the detection of the cytokines in serum samples from subjects with ulcerative colitis, Crohn's disease, rheumatoid arthritis, and psoriasis were examined. The findings showed that the detection of the cytokines was highly dependent upon the platform, with the consistency of the detection of cytokines across platforms being dependent upon the cytokine being analyzed. A careful examination of platform assay performance must be made prior to utilizing multiplex platforms in a study. While some cytokines will give similar patterns of results across platforms, others will be highly variable. The use of the same platform within a study or across studies where data will be compared is advised.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18003817      PMCID: PMC2223861          DOI: 10.1128/CVI.00211-07

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  19 in total

1.  High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA).

Authors:  L G Mendoza; P McQuary; A Mongan; R Gangadharan; S Brignac; M Eggers
Journal:  Biotechniques       Date:  1999-10       Impact factor: 1.993

2.  Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers.

Authors:  Sameena S Khan; Meghan S Smith; Debra Reda; Anthony F Suffredini; J Philip McCoy
Journal:  Cytometry B Clin Cytom       Date:  2004-09       Impact factor: 3.058

3.  Heterophile antibody interference in a multiplexed fluorescent microsphere immunoassay for quantitation of cytokines in human serum.

Authors:  Thomas B Martins; Brian M Pasi; Christine M Litwin; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

4.  Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies.

Authors:  Wilco de Jager; Berent J Prakken; Johannes W J Bijlsma; Wietse Kuis; Ger T Rijkers
Journal:  J Immunol Methods       Date:  2005-05       Impact factor: 2.303

5.  Comparison of three multiplex cytokine analysis systems: Luminex, SearchLight and FAST Quant.

Authors:  Gendie E Lash; Paula J Scaife; Barbara A Innes; Harry A Otun; Steven C Robson; Roger F Searle; Judith N Bulmer
Journal:  J Immunol Methods       Date:  2006-01-18       Impact factor: 2.303

Review 6.  Chemokines: role in inflammation and immune surveillance.

Authors:  B Moser; K Willimann
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

7.  Variables that affect assays for plasma cytokines and soluble activation markers.

Authors:  N Aziz; P Nishanian; R Mitsuyasu; R Detels; J L Fahey
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

8.  Validation and comparative analysis of a multiplexed assay for the simultaneous quantitative measurement of Th1/Th2 cytokines in human serum and human peripheral blood mononuclear cell culture supernatants.

Authors:  Uma Prabhakar; Edward Eirikis; Manjula Reddy; Eva Silvestro; Susan Spitz; Charles Pendley; Hugh M Davis; Bruce E Miller
Journal:  J Immunol Methods       Date:  2004-08       Impact factor: 2.303

9.  Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.

Authors:  J L Fahey; J M Taylor; B Manna; P Nishanian; N Aziz; J V Giorgi; R Detels
Journal:  AIDS       Date:  1998-09-10       Impact factor: 4.177

10.  Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells.

Authors:  Wilco de Jager; Henk te Velthuis; Berent J Prakken; Wietse Kuis; Ger T Rijkers
Journal:  Clin Diagn Lab Immunol       Date:  2003-01
View more
  24 in total

1.  Accuracy and reproducibility of a multiplex immunoassay platform: a validation study.

Authors:  Julie A Bastarache; Tatsuki Koyama; Nancy E Wickersham; Daphne B Mitchell; Ray L Mernaugh; Lorraine B Ware
Journal:  J Immunol Methods       Date:  2011-01-26       Impact factor: 2.303

2.  Single molecule enzyme-linked immunosorbent assays: theoretical considerations.

Authors:  Lei Chang; David M Rissin; David R Fournier; Tomasz Piech; Purvish P Patel; David H Wilson; David C Duffy
Journal:  J Immunol Methods       Date:  2012-02-20       Impact factor: 2.303

3.  An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Authors:  Thomas S Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

4.  Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.

Authors:  J A Bastarache; T Koyama; N E Wickersham; L B Ware
Journal:  J Immunol Methods       Date:  2014-04-21       Impact factor: 2.303

5.  Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance).

Authors:  Andrew B Nixon; Herbert Pang; Mark D Starr; Paula N Friedman; Monica M Bertagnolli; Hedy L Kindler; Richard M Goldberg; Alan P Venook; Herbert I Hurwitz
Journal:  Clin Cancer Res       Date:  2013-10-04       Impact factor: 12.531

Review 6.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 7.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

8.  Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs.

Authors:  K Brookes; J Cummings; A Backen; A Greystoke; T Ward; G C Jayson; C Dive
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

Review 9.  Integrated review of the association of cytokines with fibromyalgia and fibromyalgia core symptoms.

Authors:  Victoria Menzies; Debra E Lyon
Journal:  Biol Res Nurs       Date:  2009-11-22       Impact factor: 2.522

10.  Meso scale discovery and luminex comparative analysis of calbindin D28K.

Authors:  Samer Sourial; Maritha Marcusson-Ståhl; Karin Cederbrant
Journal:  J Biomed Biotechnol       Date:  2009-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.